Proteomic age measure

1. Proteomic age measure has no effect on grip strength in humans.

   “but not correlated with fasting glucose, grip strength or MRI-derived temporal meta-ROI.”

   Humans

   A PROTEOMICS-BASED MEASURE OF ACCELERATING AGING IS CORRELATED WITH THE BRAIN AGE GAP IN THE ARIC STUDY · GSA 2024 abstract · 31 Dec 2024

Grip strength →

1. Proteomic age measure is associated with gait speed in humans (0.24).

   “gait speed (0.24 p< 0.001)”

   Humans

   A PROTEOMICS-BASED MEASURE OF ACCELERATING AGING IS CORRELATED WITH THE BRAIN AGE GAP IN THE ARIC STUDY · GSA 2024 abstract · 31 Dec 2024

Gait speed →

1. Proteomic age measure is associated with diabetes in humans (0.18).

   “diabetes (0.18 p< 0.001)”

   Humans

   A PROTEOMICS-BASED MEASURE OF ACCELERATING AGING IS CORRELATED WITH THE BRAIN AGE GAP IN THE ARIC STUDY · GSA 2024 abstract · 31 Dec 2024

Diabetes →

1. Proteomic age measure is associated with hypertension in humans (0.25).

   “hypertension (0.25 p< 0.001)”

   Humans

   A PROTEOMICS-BASED MEASURE OF ACCELERATING AGING IS CORRELATED WITH THE BRAIN AGE GAP IN THE ARIC STUDY · GSA 2024 abstract · 31 Dec 2024

Hypertension →

1. Proteomic age measure is associated with brain age gap in humans (0.26).

   “The proteomic age measure was correlated with the brain age gap (0.26 p< 0.001)”

   Humans

   A PROTEOMICS-BASED MEASURE OF ACCELERATING AGING IS CORRELATED WITH THE BRAIN AGE GAP IN THE ARIC STUDY · GSA 2024 abstract · 31 Dec 2024

Brain age gap →